Name | Number of supported studies | Average coverage | |
---|---|---|---|
regulatory T cell | 4 studies | 30% ± 14% | |
memory B cell | 3 studies | 25% ± 8% | |
CD4-positive, alpha-beta T cell | 3 studies | 33% ± 12% | |
effector CD8-positive, alpha-beta T cell | 3 studies | 38% ± 17% |
Insufficient scRNA-seq data for expression of CD70 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 64% | 21.79 | 57 / 89 | 80% | 74.39 | 720 / 901 |
lung | 86% | 33.47 | 499 / 578 | 41% | 4.86 | 475 / 1155 |
skin | 75% | 38.26 | 1357 / 1809 | 52% | 7.64 | 245 / 472 |
intestine | 69% | 34.65 | 665 / 966 | 44% | 4.92 | 232 / 527 |
esophagus | 67% | 22.79 | 971 / 1445 | 45% | 5.21 | 82 / 183 |
lymph node | 0% | 0 | 0 / 0 | 100% | 94.20 | 29 / 29 |
spleen | 100% | 113.87 | 241 / 241 | 0% | 0 | 0 / 0 |
uterus | 38% | 7.61 | 65 / 170 | 55% | 14.55 | 252 / 459 |
peripheral blood | 93% | 2969.21 | 861 / 929 | 0% | 0 | 0 / 0 |
thymus | 51% | 12.43 | 336 / 653 | 41% | 4.90 | 246 / 605 |
stomach | 35% | 6.89 | 124 / 359 | 51% | 5.90 | 145 / 286 |
breast | 56% | 18.57 | 257 / 459 | 26% | 1.28 | 290 / 1118 |
adipose | 79% | 66.58 | 955 / 1204 | 0% | 0 | 0 / 0 |
bladder | 43% | 8.48 | 9 / 21 | 36% | 5.25 | 182 / 504 |
tonsil | 0% | 0 | 0 / 0 | 76% | 11.80 | 34 / 45 |
pancreas | 5% | 0.62 | 15 / 328 | 46% | 3.90 | 82 / 178 |
prostate | 34% | 4.74 | 84 / 245 | 1% | 0.04 | 6 / 502 |
blood vessel | 34% | 8.68 | 458 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 31% | 3.24 | 25 / 80 |
brain | 18% | 2.83 | 463 / 2642 | 11% | 2.14 | 80 / 705 |
ovary | 4% | 0.59 | 8 / 180 | 17% | 1.73 | 75 / 430 |
liver | 14% | 1.86 | 31 / 226 | 5% | 0.80 | 21 / 406 |
adrenal gland | 11% | 1.26 | 28 / 258 | 2% | 1.13 | 5 / 230 |
heart | 12% | 2.35 | 107 / 861 | 0% | 0 | 0 / 0 |
muscle | 10% | 1.40 | 77 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097191 | Biological process | extrinsic apoptotic signaling pathway |
GO_0042102 | Biological process | positive regulation of T cell proliferation |
GO_0042100 | Biological process | B cell proliferation |
GO_0090717 | Biological process | adaptive immune memory response involving T cells and B cells |
GO_0002456 | Biological process | T cell mediated immunity |
GO_0019724 | Biological process | B cell mediated immunity |
GO_0042110 | Biological process | T cell activation |
GO_0033209 | Biological process | tumor necrosis factor-mediated signaling pathway |
GO_0160162 | Biological process | CD27 signaling pathway |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0005164 | Molecular function | tumor necrosis factor receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0048018 | Molecular function | receptor ligand activity |
Gene name | CD70 |
Protein name | CD70 antigen (CD27 ligand) (CD27-L) (Tumor necrosis factor ligand superfamily member 7) (CD antigen CD70) CD70 molecule |
Synonyms | CD27LG CD27L TNFSF7 |
Description | FUNCTION: Cytokine which is the ligand for CD27. The CD70-CD27 pathway plays an important role in the generation and maintenance of T cell immunity, in particular during antiviral responses. Upon CD27 binding, induces the proliferation of costimulated T-cells and enhances the generation of cytolytic T-cells. . |
Accessions | ENST00000245903.4 [P32970-1] P32970 ENST00000423145.7 [P32970-2] M0QZW2 ENST00000597430.2 |